scispace - formally typeset
R

Richard J. Brand

Researcher at University of California, San Francisco

Publications -  107
Citations -  14164

Richard J. Brand is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Population & Risk factor. The author has an hindex of 47, co-authored 106 publications receiving 13605 citations. Previous affiliations of Richard J. Brand include University of California, Berkeley & Kaiser Permanente.

Papers
More filters
Journal ArticleDOI

Can lifestyle changes reverse coronary heart disease?: The Lifestyle Heart Trial

TL;DR: Comprehensive lifestyle changes may be able to bring about regression of even severe coronary atherosclerosis after only 1 year, without use of lipid-lowering drugs.
Journal ArticleDOI

Intensive lifestyle changes for reversal of coronary heart disease.

TL;DR: More regression of coronary atherosclerosis occurred after 5 years than after 1 year in the experimental group, and in the control group, coronary Atherosclerosis continued to progress and more than twice as many cardiac events occurred.
Journal ArticleDOI

Coronary heart disease in Western Collaborative Group Study. Final follow-up experience of 8 1/2 years

TL;DR: In this paper, the authors found that the type A behavior pattern was strongly related to the CHD incidence, and this association could not be explained by association of behavior pattern with any single predictive risk factor or with any combination of them.
Journal ArticleDOI

Selective referral to high-volume hospitals: estimating potentially avoidable deaths.

TL;DR: Initiatives to facilitate referral of patients to HVHs have the potential to reduce overall hospital mortality in California for the conditions identified and to determine the extent to which selective referral is feasible and to examine the potential consequences.
Journal ArticleDOI

Epidemiology as a Guide to Clinical Decisions. The Association Between Triglyceride and Coronary Heart Disease

TL;DR: It is recommended that widespread screening and treatment of healthy persons for hypertriglyceridemia be abandoned until more persuasive evidence becomes available, and it is proposed that the ethics of preventive medicine place the burden of proof on the proponents of intervention.